Faradarmani Consciousness Field Treatment Reduces MDA-MB-231 Cancer Cell Viability

Abstract

Breast cancer is the most common form of malignancy among women worldwide and is a multifactorial disease, the development of which involves various factors. The Faradarmani Consciousness Field (FCF) was introduced by Mohammad Ali Taheri as one of many Consciousness Fields that are neither energy nor matter, nor are they quantifiable; thus they cannot be directly observed or measured. However, it is possible to evaluate their effects indirectly through controlled experiments in the laboratory. This study aimed to investigate the effect of FCF on breast cancer cells (MDA-MB-231) measured using MTT and flow cytometry methods at 24, 48, and 72 hours. First, the MDA-MB-231 cell line was cultured, then the effect of FCF was studied at 24, 48, and 72 hours. To determine the cell death in the sample treated with FCF and compare it with the control, cells were stained with Annexin-V and propidium iodide (PI). Our results showed that the measured survival in the MTT test, at 24 hours, showed a 16% decrease in the experimental sample compared to the control. At this time, the percentage of early and late apoptosis and total apoptosis and necrosis in the sample under the influence of the FCF compared to the control cell lines increased by 5.92%, 3.49%, 9.41% and 4.68% respectively. Finally, the rate of programmed death of cancer cells increased in time intervals of 24 (9.41 %), 48 (21.44 %) and 72 (23.04 %) hours under the influence of this field in the examined cell line.